With more than 50 years of combined experience, our founders lead the field in safety protocols, research, and the delivery of innovative, human-centric care.

José is first exposed to ibogaine while working as an EMT in Mexico.
Jonathan begins clinical work in ibogaine treatment in Mexico.
José begins formal ibogaine treatments and develops early safety protocols.
Trevor launches Liberty Root Therapy to provide legal ibogaine treatment in Canada.
Jonathan becomes Executive Director of the Global Ibogaine Therapy Alliance (GITA).
Jonathan receives Dissoumba/Fang Bwiti initiation in Gabon.
Jonathan publishes Clinical Guidelines for Ibogaine-Assisted Detoxification.
José develops screening and treatment methodologies to reduce mortality rates in ibogaine clinics.
Trevor joins the board of directors as Board Chair for MAPS Canada.
José founds Nouvelle Vie clinic in Mexico, a precursor to Ambio Life Sciences.
Trevor co-founds the Canadian Psychedelic Association.
Trevor featured in award-winning Dosed documentary.
Ambio Life Sciences is founded by Trevor, Jonathan, and José and expands to new clinic locations throughout Baja California.
Jonathan receives Missoko Bwiti initiation in Gabon.
Ambio becomes the first and only Nagoya-compliant ibogaine clinic in the world.
Filed the first Nagoya-compliant patents for Ambio’s unique safety protocol, the use of ibogaine to treat MS, and its use in post-stroke recovery.
Ambio founders co-author groundbreaking Nature Medicine publication with Stanford University on ibogaine for veteran traumatic brain injury.
Ambio co-authors case report in Frontiers showing unprecedented lesion reduction in ibogaine patients with multiple sclerosis.
Ambio launches world’s first Neuroregenerative Program for patients with Parkinson’s, MS, and other conditions.
Ambio is featured in a Netflix documentary, In Waves & War.
Ambio becomes the world’s first transcontinental ibogaine clinic with a European expansion + the opening of its Malta clinic.
Ambio operates five private residential clinics in Baja California, each delivering world-class ibogaine care in a secure, serene environment. Our facilities are not hospitals or retreat centers – they are healing spaces designed for safety, comfort, and transformation.
Each location is program-specific and staffed by our full clinical, therapeutic, and hospitality teams, widely regarded as best-in-class. Treatment is administered in settings that are medically equipped to the standard of a cardiac ICU, yet designed with the tranquility of a boutique resort. Rooted in clinical excellence and shaped by years of experience, our Mexico sites reflect the cultural depth of their surroundings – with traditional Mexican design elements, locally sourced cuisine, and a deep respect for the land and lineage of Baja.
Opening in early 2026, Ambio Malta is our first international clinic and the first ibogaine facility of its kind in Europe. Located on the Mediterranean island of Malta, this site offers the same clinical excellence, medical safety, and therapeutic support that define our work and reputation in North America – now in a Mediterranean setting rich with history, beauty, and soul.
With programming focused on mental health, TBI, and personal optimization, punctuated by stunning views of Mellieha Bay & the Mediterranean Sea, Ambio Malta serves guests seeking relief from trauma, anxiety, depression, and more. The serene residential clinic blends Mediterranean architecture, locally rooted somatic therapies, and a tranquil coastal atmosphere – all delivered with Ambio’s signature quality, clinical rigor, and heart.
For the privacy and protection of our patients, addresses of our treatment facilities are not publicly disclosed. Safety is our highest priority – from medical oversight to personal security. All clients are transported to and from our clinics via private, trained drivers, and patients are never left unescorted. Our houses are staffed around the clock and monitored closely to ensure continuous safety, comfort, and peace of mind.